Examining New Treatment Strategies Aimed at Stroke Prevention in Patients with Atrial Fibrillation: A Multidisciplinary Discussion

, ,
Pharmacy Times, March 2014 Mental Health, Volume 80, Issue 3

Pharmacists can learn about educating patients on the risk of stroke in atrial fibrillation, monitoring anticoagulation therapy, and participating in disease management opportunities.

This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Examining New Treatment Strategies Aimed at Stroke Prevention in Patients with Atrial Fibrillation: A Multidisciplinary Discussion

Jennifer Costello, PharmD, BCPS, BC-ADM

Ambulatory Clinical Pharmacist

Internal Medicine Faculty Pharmacist

Saint Barnabas Medical Center

Livingston, New Jersey

Mindy Houng, MD, FACP

Associate Program Director

Internal Medicine Residency Program

Department of Medicine

Saint Barnabas Medical Center

Livingston, New Jersey

Clinical Assistant Professor

Department of Medicine

Rutgers University, New Jersey

Medical School

Newark, New Jersey

Steven J. Sheris, MD, FACC, FACP

Chief of Cardiology

Overlook Medical Center

Gagnon Cardiovascular Institute

Summit, New Jersey

Disclosures

The following contributors have no relevant financial relationships with commercial interests to disclose

Faculty

Jennifer Costello, PharmD, BCPS, BC-ADM

Mindy Houng, MD, FACP

Steven J. Sheris, MD, FACC, FACP

Pharmacy Times Office of Continuing Professional Education

Planning StaffDavid Heckard; Steve Lin, PharmD, RPh; Maryjo Dixon, RPh; and Donna Fausak

Pharmacy Times

Editorial StaffBea Riemschneider and Kirk McKay

An anonymous peer reviewer was part of the content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.

Educational Objective

At the conclusion of this educational activity, participants should be able to:

  • Discuss the prevalence, epidemiology, and risk of stroke in patients with atrial fibrillation (AF).
  • Explore the underrecognized risk of stroke and inadequate prophylaxis in patients with AF.
  • Examine current guidelines, with respect to risk stratification recommendations for appropriate anticoagulation, and impact on patient outcomes.
  • Review newly approved oral anticoagulants and identify their practice-focused differences from warfarin and their role in stroke prevention.
  • Explore the pharmacist’s role in educating patients on the risk of stroke in AF, monitoring anticoagulation therapy, and participating in disease management opportunities.

Target audience: Pharmacists

Type of activity: Knowledge

Release date: March 12, 2014

Expiration date: March 12, 2016

Estimated time to complete activity: 2 hours

Fee: Free

Click here to view this activity.

Pharmacy Times Office of Continuing Professional Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 2.0 contact hours (0.2 CEUs) under the ACPE universal activity number 0290-0000-14-015-H01-P. The activity is available for CE credit through March 12, 2016.